NCT06625190 2026-03-11Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid TumorsUniversity of FloridaPhase 1/2 Recruiting27 enrolled
NCT06239272 2026-01-26NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)St. Jude Children's Research HospitalPhase 1/2 Recruiting139 enrolled
NCT06244420 2025-04-01Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to PrognosisIstituto Ortopedico RizzoliCompleted33 enrolled
NCT03600649 2023-11-21Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasSalarius Pharmaceuticals, LLCPhase 1 Unknown50 enrolled
NCT05266196 2023-08-01A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)Salarius Pharmaceuticals, LLCPhase 1/2 Unknown10 enrolled